A Study to Evaluate ASP0367 in Participants With Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction
Clinical trial NCT04855201 · TERMINATED
Trial details
- NCT number
- NCT04855201
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-14
- Primary completion
- 2022-12-16
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.